Biogen's New Alzheimer's Drug Will Cost $56,000 Per Year

Biogen set the list price for Aduhelm, its newly approved treatment, and is collaborating with CVS to improve screening for the disease.... Read more

Bron:

Fool.com: The Motley Fool